CooperStrokedat: Data for the stroke prevention NMA-network discussed in...
In nmaINLA: Network Meta-Analysis using Integrated Nested Laplace Approximations

The stroke prevention dataset describes a network comparing 17 treatments with 26 trials.

1	CooperStrokedat

A data frame with 26 observations on the following 17 variables.

r1: Number of events (responses) in the baseline treatment (treatment 1).
r2: Number of events (responses) in the second study arm treatment (treatment 2).
r3: Number of events (responses) in the third study arm treatment (treatment 3).
r4: Number of events (responses) in the third study arm treatment (treatment 4).
r5: Number of events (responses) in the third study arm treatment (treatment 5).
n1: Total number of study participants in the baseline treatment (treatment 1).
n2: Total number of study participants in the second study arm treatment (treatment 2).
n3: Total number of study participants in the second study arm treatment (treatment 3).
n4: Total number of study participants in the second study arm treatment (treatment 4).
n5: Total number of study participants in the second study arm treatment (treatment 5).
t1: Indicator variable identifying treatment 1.
t2: Indicator variable identifying treatment 2.
t3: Indicator variable identifying treatment 3.
t4: Indicator variable identifying treatment 4.
t5: Indicator variable identifying treatment 5.
na: Indicator with number of arms in trial.
cov: Covariate, study-specific covariates
des: Design, the set of treatments included in each study

Cooper, N.J., Sutton, A.J., Morris, D., Ades, A.E. and Welton, N.J., 2009. Addressing between-study heterogeneity and inconsistency in mixed treatment comparisons: Application to stroke prevention treatments in individuals with non-rheumatic atrial fibrillation. Statistics in medicine, 28(14), pp.1861-1881.

nmaINLA documentation built on July 22, 2021, 1:05 a.m.